Abeona Therapeutics Inc. (ABEO)
NASDAQ: ABEO · Real-Time Price · USD
4.460
-0.300 (-6.30%)
Apr 1, 2025, 3:55 PM EDT - Market open
Abeona Therapeutics Employees
Abeona Therapeutics had 84 employees as of December 31, 2023. The number of employees increased by 27 or 47.37% compared to the previous year.
Employees
84
Change (1Y)
27
Growth (1Y)
47.37%
Revenue / Employee
n/a
Profits / Employee
-$758,738
Market Cap
216.46M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
ABEO News
- 8 hours ago - Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 12 days ago - Abeona Therapeutics Inc. (ABEO) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 12 days ago - Abeona Therapeutics® Reports Full Year 2024 Financial Results, Provides Pz-cel Regulatory Update and Commercial Launch Plans - GlobeNewsWire
- 4 weeks ago - Abeona Therapeutics® to Present at the Leerink Partners Global Healthcare Conference - GlobeNewsWire
- 4 weeks ago - Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 2 months ago - Abeona Therapeutics: Despite Some Competitive Pressure, This Looks Undervalued - Seeking Alpha
- 4 months ago - Abeona Therapeutics® Reports Third Quarter 2024 Financial Results and Recent Corporate Updates - GlobeNewsWire
- 5 months ago - Abeona Therapeutics® Announces FDA Acceptance of BLA Resubmission of Pz-cel for the Treatment of Recessive Dystrophic Epidermolysis Bullosa - GlobeNewsWire